Pharnext SA (ALPHA) - Financial and Strategic SWOT Analysis Review

  • ID: 4278679
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Pharnext SA (Pharnext), formerly Pharnext SAS is a clinical stage biopharmaceutical company that develops new treatments for severe orphan and common neurological disorders. The company’s proprietary research and development platform is based on network pharmacology that uses wide genomic data to identify molecules related to specific diseases and facilitates the development of synergistic combinations of drugs. Its lead pleodrugs in clinical development include PXT-3003, for Charcot-Marie-Tooth disease type 1A currently in Phase III trials; and PXT-864, for Alzheimer’s disease and other neurological indications including Parkinson’s disease and amyotrophic lateral sclerosis currently in Phase II trials. The company also identifies and develops synergistic combinations of repositioned drugs at small doses. Pharnext is headquartered in Paris, France.

Pharnext SA Key Recent Developments

Jan 02, 2018: Dr. Philippe Chambon Joins Pharnext’s Board of Directors
Oct 19, 2017: Pharnext: First-Half 2017
Jun 20, 2017: Pharnext to Showcase Pioneering PLEOTHERAPY R&D Platform at 6th Annual Drug Repositioning, Repurposing and Rescue Conference
Apr 26, 2017: Pharnext Reports Year End 2016 Financial Results
Feb 02, 2017: Pharnext Announces Findings Evaluating Charcot-Marie-Tooth Neuropathy Score

This comprehensive SWOT profile of Pharnext SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pharnext SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Pharnext SA - Key Information
  • Pharnext SA - Overview
  • Pharnext SA - Key Employees
  • Pharnext SA - Key Employee Biographies
  • Pharnext SA - Key Operational Heads
  • Pharnext SA - Major Products and Services
  • Pharnext SA - History
  • Pharnext SA - Company Statement
  • Pharnext SA - Locations And Subsidiaries
  • Pharnext SA - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Pharnext SA - Business Description
  • Pharnext SA - Corporate Strategy
  • Pharnext SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Pharnext SA - Strengths
  • Pharnext SA - Weaknesses
  • Pharnext SA - Opportunities
  • Pharnext SA - Threats
  • Pharnext SA - Key Competitors
Section 3 - Company Financial Performance Charts
  • Pharnext SA - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Pharnext SA, Key Information
  • Pharnext SA, Key Ratios
  • Pharnext SA, Share Data
  • Pharnext SA, Major Products and Services
  • Pharnext SA, History
  • Pharnext SA, Key Employees
  • Pharnext SA, Key Employee Biographies
  • Pharnext SA, Key Operational Heads
  • Pharnext SA, Other Locations
  • Pharnext SA, Subsidiaries
  • Pharnext SA, Key Manufacturing facilities
  • Pharnext SA, Key Competitors
  • Pharnext SA, SWOT Analysis
  • Pharnext SA, Ratios based on current share price
  • Pharnext SA, Annual Ratios
  • Pharnext SA, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Pharnext SA, Performance Chart
  • Pharnext SA, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll